News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for Triple negative breast cancer is out in Molecular Cancer Therapeutics today. – Polyak Lab
Photo from Polyak Lab/Twitter
Sep 11, 2023, 00:27

Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for Triple negative breast cancer is out in Molecular Cancer Therapeutics today. – Polyak Lab

Polyak Lab recently shared on X/Twitter:

“Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for TNBC is out in Molecular Cancer Therapeutics today. Congrats to all the coauthors! And of course a lot more to be explored in the future.”

Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for Triple negative breast cancer is out in Molecular Cancer Therapeutics today. - Polyak Lab

For the article click here.
Source: Polyak Lab/Twitter

anti-PD-L1 BRD4 inhibitor cancer Molecular Cancer Therapeutics OncoDaily Oncology Paclitaxel Polyak Lab TNBC
Special Coverage
Insight
Sep 1, 2024, 09:56
Billy Rosa: Are Palliative Care specialists expected to provide extra support to primary team members
Insight
Sep 1, 2024, 09:53
Maximilian Mair: Translating the theranostic concept to neurooncology
Blog
Sep 1, 2024, 09:51
Sara Gutiérrez-Enríquez: Our Work on hereditary breast/ovarian cancer and Radiogenomics
Insight
Sep 1, 2024, 09:48
Phase III Keynote-789 Trial of Platinum + Pemetrexed +/- Pembrolizumab in EGFR + NSCLC
Blog
Sep 1, 2024, 09:23
Estela Rodriguez: The Inaugural class of Sylvester Comprehensive Cancer Center Emerging Leaders Program
Insight
Sep 1, 2024, 09:17
Geriatric assessment in oncology by Allison Magnuson et al.
Insight
Sep 1, 2024, 09:14
Power Of Metals Gold, Silver, and Copper in Our Daily Lives and Cancer Treatment - The Babak Lab
Insight
Sep 1, 2024, 09:07
Springboard Enterprises's 2024 Healthcare and Technology Council
Insight
Sep 1, 2024, 09:02
Narjust Florez is one of the co-chairs at this year’s WCLC - Florez Lab
Blog
Sep 1, 2024, 09:00
Nishant Rajendra Tiwari: Ryan Nipp on Practical considerations in Academic Medicine at OU Health Stephenson Cancer Center
Insight
Sep 1, 2024, 08:30
Sacituzumab Govitecan in cisplatin-ineligible metastatic urothelial cancer after CPI
Insight
Sep 1, 2024, 08:24
Rahul Banerjee: Chronicle disparities in Relapsed or Refractory myeloma and why they matter